Cookies | Search For A Share Price | 

Uk Share Prices

Hemogenyx Pharmaceuticals Plc is a biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces the readmission of its enlarged issued share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The Company is the holding company for Hemogenyx LLC, a US-based biotechnology company developing therapies to transform bone marrow and blood stem cell transplantation. These therapies will replace the need for existing methods of preparation of patients for a transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation.
Trend Direction
1 Day 1 Week 1 Month
Hemogenyx Pharmaceuticals - (HEMO) share price history
Date Open High Low Close Volume
23/09/2020 10.48 10.48 9.85 10.25 1,514,777
22/09/2020 10.05 11.00 9.42 10.50 3,005,043
21/09/2020 10.30 10.41 10.00 10.10 2,615,559
18/09/2020 10.35 10.94 10.02 10.30 2,528,932
17/09/2020 10.29 10.40 10.00 10.20 1,528,451
More Hemogenyx Pharmaceuticals History
Latest Hemogenyx Pharmaceuticals share news
More Hemogenyx Pharmaceuticals HEMO.L share news »

Top Volume Pharmaceuticals & Biotechnology Shares Price %Chng
Valirx 52.00 30.00%
Sareum Holdings 0.75 -0.66%
GlaxoSmithKline 1,493.40 0.93%
N4 Pharma 6.30 23.53%
Gunsynd 1.33 -1.85%
4D Pharma 167.00 7.74%
PureTech Health 256.00 -0.19%
Genedrive 124.00 -10.79%
AstraZeneca 8,812.00 2.70%
Scancell Holdings 16.63 7.26%
View all sectors »
Hemogenyx Pharmaceuticals Share chat - Message board.

Data for Hemogenyx Pharmaceuticals is end of day only and updates after midnight GMT. Data is gathered from historic databases such as Quandl and other reliable sources, however errors do occur. Please use for information purposes only.
Enter share symbol
Search share prices A to Z